Researchers report a minimally invasive procedure may assist patients maintain weight loss after stopping Ozempic or Wegovy. Duodenal mucosal resurfacing shows early promise in weight maintenance … Read more
The surge in prescriptions for GLP-1 receptor agonists—including medications like Ozempic, Wegovy, and Mounjaro—has brought unprecedented weight loss results to millions. However, as these drugs develop … Read more
The landscape of obesity drug sales in India is undergoing a fundamental shift as the arrival of lower-cost generics begins to challenge the dominance of premium … Read more
While global headlines were dominated by the volatility of the Iran war and shifting geopolitical alliances, a quieter but equally consequential milestone occurred in the pharmaceutical … Read more
The medical world is currently witnessing a paradigm shift in the treatment of obesity, driven by a new class of medications that offer weight loss results … Read more
Television presenter Alison Hammond has firmly denied speculation that she used weight-loss medications to achieve her recent transformation, attributing her 11-stone weight loss to a rigorous … Read more
The expiration of key patents on GLP-1 receptor agonists – a class of drugs initially developed for diabetes but increasingly used for weight loss, including popular … Read more
The allure of a quick fix for weight loss is nothing new, but a growing trend is raising serious health concerns: the non-medical apply of medications … Read more
